The Antithrombin Activity of Human Plasma BY J. W. LYTTLETON* (Received 15 February 1954) The presence of an agent in serum capable of progressively inactivating the thrombin formed during the coagulation of blood or plasma has long been recognized. After it had been suggested that the factor involved in this action was protein in nature (Rettger, 1909) , three main ideas were put forward as to the method of inactivation. Landsberg (1913) considered that thrombin was inactivated by a reversible non-specific adsorption on to serum albumin; Collingwood & MacMahon (1912) held that thrombin was destroyed by a specific enzyme in serum ; and Howell (1916) and his co-workers maintained that thrombin was rendered inactive by combination with a specific protein, the product of this combination being termed metathrombin.
More recent work has shown that antithrombin occurs in the albumin fraction of serum as obtained by salt precipitation (Lenggenhager, 1935; Quick, 1938; Stewart & Rourke, 1940; Astrup & Darling, 1942) , but the factor itself has not been isolated. Astrup & Darling (1942) , working with bovine materials, described a method for the quantitative estimation of antithrombin based on the fact that a given quantity is capable of inactivating only a definite number of thrombin units, and that this inactivation is complete in 15 min. Several observations recorded in the literature indicated that this method of measurement might not be directly applicable to the estimation ofhuman antithrombin. Both Collingwood & MacMahon (1913) and Quick (1938) , working with human materials, observed that thrombin inactivation continues for at least 30 min., while Herbert (1940) found that in a given time human serum would inactivate a definite fraction of the thrombin present, independent of its absolute concentration.
These apparent differences between the behaviour of human and bovine antithrombin indicated that a more complete examination of the reaction between human thrombin and human antithrombin might yield new information.
MATERIALS AND METHODS
Veronal buffer. Unless the contrary is stated, all the dilutions of materials used were carried out with a veronal buffer (Michaelis, 1930) of pH 7 3, I =0-15. Two litres of this buffer contained 215 ml. 0-2N-HCl, 14-43 g. NaCl, and 11F74 g. Na barbiturate.
Fibrinogen. The estimation of antithrombin depends on measuring the inactivation of thrombin, and the strength of thrombin is measurable only in terms of the rate of coagulation of fibrinogen, whether this be native fibrinogen in plasma or a solution of fibrinogen purified by fractionation.
In these experiments a solution of bovine fibrinogen was used as coagulation substrate, the fibrinogen being obtained by precipitation from bovine plasma by addition of 0 11 vol. ether at O°. Thrombin. Human thrombin was prepared by a method developed from that devised by Kekwick, Mackay & Record (1946) (see also Kekwick & Mackay, 1954) . After precipitating the fibrinogen from citrated human plasma by the addition of 0-11 vol. ether at 00 the supernatant solution was adjusted to pH 5-3 by the addition of 0-5M acetic acid (130-135 ml./l.). The precipitate of crude prothrombin formed at 00 was centrifuged down and washed twice by resuspending in distilled water at 00 and again centrifuging down. The washed precipitate was dissolved in veronal buffer pH 7-3, 1=0-15, and reprecipitated by reducing the ionic strength to I =0-033 and then adjusting the pH to 5-3 with 0-1 M acetic acid. After redissolving in citrate saline to 1/10 original plasma volume and neutralizing, this prothrombin was converted into thrombin by addition of human placental thromboplastin and CaCl2. When the conversion was complete, the thrombin was partially purified by adding 0-1 vol. ether at 00 and adjusting the pH to 5 3, when a large proportion of the contaminating impurities was precipitated. The thrombin solution was adjusted to pH 7-3 by dialysis against veronal buffer pH 7 3, 1=0-15, and freezedried in 10 ml. samples. This provided a suitable standard, effectively free from contamination with antithrombin. The thrombin activity was 93 units/mg. protein N.
Thrombin unit. The unit used was that defined by Owren (1947) . According to this definition one thrombin unit is equal to the amount of thrombin which, in a volume of 1 ml. containing 0-10-0-15 g./100 ml. human fibrinogen at 370, pH 7 3, and I =0-15, due to NaCl, will cause a clot to form in 15 sec. This is a modification of the Iowa unit (Warner, Brinkhous & Smith, 1936) in which the temperature used was 280.
The veronal buffer used as a diluent in these experiments has been shown by Owren (1947) (Philpot, 1938) , the light source being a high-pressure mercury arc from which monochromatic light, A = 546 m,u., was isolated.
The same Tiselius apparatus was used in early work on separating the components of plasma by lateral displacement of the two intermediate sections of the U-tube at the conclusion of a run. In later work the flow-through apparatus (Kekwick, Lyttleton, Brewer & Dreblow, 1951) their method of measuring antithrombin in terms of the number of thrombin units inactivated at the end of a reaction reaching completion in a short time (15 min.) is not applicable.
To estimate human antithrombin it is evident that the rate of thrombin inactivation rather than the ultimate amount of thrombin inactivated should be used, for Fig. 1 shows that this rate varies with the DFP concentration. To allow the amount of antithrombin in an unknown mixture to be determined from the decay curve produced when it was added to a standard thrombin solution, it was necessary to discover some property of the curves which could be related quantitatively to the known amount of DFP, or antithrombin, added to the system.
Analysis of decay curves
Kinetics of reaction. The reaction could not be described satisfactorily in terms either of first-or second-order equations. First-order constants (k1) were calculated for the curves of Figs. 1 and 2, assuming that during any one experiment the antithrombin concentration remained unchanged, and arbitrarily defining an antithrombin unit such that 1 ml. DFP contained 50 units of antithrombin, a definition used in all subsequent calculations.
The values obtained for k1 decreased from 0-006-0-008 at 5 min. to 0-002-0-003 at 50 min., but the uniformity of behaviour and small random variations in kI for the fivefold variation in initial thrombin concentration and 20-fold variation in antithrombin concentration, indicated that the type of reaction occurring was constant within the concentration range considered.
Although an approximately constant value for the second-order reaction constant could be derived from the curves of Fig. 1 (Bodansky, 1937) . Both of these methods gave values for the reaction velocity which were linearly related to the amount of antithrombin added to the system, provided that the reaction was not nearing completion.
The standard method adopted was to determine from the inactivation curve the percentage of thrombin inactivated in the first 10 min. of the reaction, and to refer this to a calibration curve in which the 10 min. percentage inactivation was plotted against the amount of DFP present in the system (Fig. 3) . This calibration was valid for initial thrombin concentrations of 2-12 units/ml., and enabled the amount of antithrombin present in an unknown system to be determined in terms of DFP. The unit of antithrombin was arbitrarily defined as 1 unit _ 0 02 ml. DFP, so in a reaction mixture of 5 ml., 0.1 ml. DFP gives 1 unit antithrombin/ml.
Reduction of antithrombin activity due to incubation with thrombin The type of reaction between thrombin and antithrombin with its progressively decreasing firstorder constant (kl) suggests that antithrombin is removed from the system as the reaction proceeds. This was confirmed by incubating samples of thrombin solution and DFP together until negligible thrombin activity remained, and then measuring the remaining antithrombin activity (Fig. 4) . Initially the amount of antithrombin activity removed increases linearly with the amount of thrombin inactivated, but the rate of removal decreases as the amount removed approaches the total amount present.
As a corollary to this observation it is to be expected that if a large excess of thrombin is added to a given amount of DFP, the antithrombin activity will be reduced to a very low value after a certain amount of thrombin has been inactivated, when the rate of thrombin decay will approach that of a control containing no antithrombin. This was confirmed by adding 1-5 antithrombin units to 25 thrombin units in 5 ml. veronal buffer. After 18 hr. incubation at 370, 15 thrombin units had been inactivated, and the thrombin decay rate was approximately equal to that of the control.
Effect of antithrombin on coagulation time offibrinogen
The variation in coagulation time on recalcification of plasma has been used as a method of measuring alitithrombin activity (Tanturi & Wetzel, 1949) . This implies that antithrombin can 1 I An influence the rate of coagulation of fibrinogen by thrombin. The conditions under which this influence was significant were investigated. Progressive dilutions of thrombin (5 units/ml.) were used to coagulate fibrinogen solutions containing various proportions of heated (10 min., 570) and unheated DFP, the heated material being added to allow for the non-progressive prolongation of coagulation time already mentioned. The effect of active antithrombin in the unheated DFP is shown by Table 1 . The immediate delaying action on coagulation, produced by both normal and heated DFP, was evident at all thrombin concentrations, whereas the additional effect of the progressive antithrombin was not significant until the coagulation time exceeded 100 sec., and not pronounced until coagulation times of the order of 400 sec. were involved. Measurement of the increase in coagulation time on addition of antithrombin to mixtures of thrombin and fibrinogen solutions is thus seen to be a very insensitive method of estimating antithrombin.
Concentration and purification of antithrombin
Identification of electrophoretic component containing antithrombin. Although the albumin fraction of serum is generally considered to be responsible for antithrombin activity (Lenggenhager, 1935; Quick, 1938; Astrup & Darling, 1942) , the albumin studied by these authors was prepared by salt fractionation in each case, and was possibly not electrophoretically pure. To investigate the activity of pure albumin, two electrophoretic runs 
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were carried out on DFP. In the first run a cut was made between the albumin and a-globulins on the ascending side. enabling albumin to be separated from this side of the U-tube and a-, fi-, and yglobulins from the descending side; while in the second run a cut was made between a-and ,Bglobulins on the descending side, yielding f,-and yglobulins on this side and albumin and a-globulin on the ascending side. Inactivation curves were then measured on addition of each of these fractions to a solution of thrombin (Fig. 5) .
The results show that electrophoretically pure albumin is not antithrombic; the antithrombin activity lies instead in the a-globulins, and follows this fraction on separation. No activity is exhibited by ,B-and y-globulins, and a mixture of all the separated plasma components (curve 5) shows no more activity than that due to the a-globulins. The antithrombin activity of human plasma thus belongs to the a-globulin fraction alone.
A similar series of runs on fresh human serum showed that in serum as well as in DFP the antithrombin activity was associated with the aglobulin fraction.
Concentration of antithrombin by salt precipitation. Fractionation of DFP by precipitation with Na2SO4 and (NH4)2SO4 at a variety ofconcentrations and pH values resulted in no concentration of antithrombin. The only conditions under which antithrombin was precipitated to any great extent were at high concentrations of ammonium sulphate (above 70 % saturated) and neutral pH values, or moderate concentration of ammonium sulphate (50 % saturated) and pH values below 4-5. Antithrombin thus appears to be among the more soluble globulins.
Concentration of antithrombin by ether precipitation. In the fractionation of human blood plasma by ether precipitation (Kekwick & Mackay, 1948 , 1954 , the fibrinogen, prothrombin-containing globulins, and a ,B-+ y-globulin fraction are successively removed from citrated plasma. The supernatant remaining contains albumin as well as the more soluble fractions of the a-and ,-globulin. From this supernatant a precipitate was obtained by lowering the pH to 5.0 at -4°, the ether content remaining at 18 % (v/v) and the ionic strength at 0-035. This precipitate contained a high proportion (30 %) of a-globulin, and will subsequently be referred to as oc-rich precipitate. The antithrombin activity of this precipitate per g. protein was 1-9 times that of DFP. Electrophoretic separation of the albumin + a-globulin fraction of this material in the flow-through U-tube increased the specific activity to 3-4 times that of DFP.
This partially purified antithrombin gave thrombin decay curves which yielded values for k, (firstorder constant) which were within the range of those measured from Figs. 1 and 2 . The kinetics of reaction thus seemed the same as with unfractionated DFP. Properties of antithrombin pH stability. The pH stability of antithrombin was examined by adjusting the pH of 10 ml. samples of DFP with 0-2N-HCl or NaOH, and incubating for 4 hr. at 37°. The solutions were then neutralized and made up to a constant volume with 0 15M-NaCl. Samples of each mixture were drawn off for pH measurement during the incubation. The antithrombin activities remaining after neutralization were measured (Fig. 6) . The antithrombin activity of DFP is stable under the conditions used between pH's 6 and 9 5, but is particularly susceptible to pH above 9 5. A second experiment, carried out in conjunction with the results described in the next section, showed that the antithrombin activity of a-rich precipitate was completely stable for 10 min. at 370 at pH values between 6 and 8.5.
Variation of activity with pH. Samples of the arich precipitate were incubated with solutions of thrombin at various pH values, and the thrombin inactivation was followed. As addition of a reaction mixture to the fibrinogen solution would change its pH, a modification of the usual method for estimating thrombin concentration was necessary to ensure that coagulation took place near pH 7.3. Samples (0.2 ml.) of the reaction mixtures were added to 0 ml. veronal buffer, pH 7-3, at 370, and 0-2 ml. of this sixfold dilution was added to 0.8 ml.
fibrinogen solution in the usual way, so that coagulation took place under the standard conditions between pH's 7 2 and 7 4. Control solutions of thrombin alone were also incubated at a series of pH values to determine how much of the thrombin inactivation occurring in the reaction mixtures was due to pH alone. The curves of Fig. 7 are corrected for this effect.
The previous section on pH stability indicates that the shape of the activity curve (Fig. 7) is not due to inactivation of antithrombin at pH values on either side of the point of maximum activity, but rather to a true pH optimum in the antithrombin activity in the vicinity of pH 7-4.
Temperature 8tabiltity. In order to examine the temperature stability of antithrombin, 10 ml.
samples of a-rich precipitate, dissolved in veronal buffer, pH 7-3, were heated to various temperatures for 10 min. in thin-walled glass tubes, chilled in cold water, and the antithrombin activities measured.
The results (Table 2) indicate that antithrombin is comparatively stable up to 500, but at 60°it is rapidly inactivated. At 370, antithrombin loses no appreciable activity in 24 hr.
Influence of temperature on activity. Identical mixtures of thrombin and cx-rich precipitate were incubated at various temperatures and the course of the reaction followed by adding 0-2 ml. samples of the mixture to 1-0 ml. veronal buffer at 370, then Curve l: l-0 ml. thrombin (50 units/ml.) +0-5 ml. oc-rich pre-cipitate+0 15N-NaOHE or 0-15w-HCI; volume adjusted to 5 ml. with veronal buffer; curve 2: as above, eDcept that 0t25ml. uo-richprecipitate used in place of 0-5 ml. VoI. 58 13 using 0-2 ml. of this sixfold dilution to produce coagulation of 0-8 ml. fibrinogen solution in the usual way. This method avoided alteration of the temperature of the coagulation mixture, so enabling the normal calibration curve to be used. Control samples of thrombin alone were heated in a similar manner in order to allow for the thermal inactivation of thrombin.
The results of Table 3 show that the percentage thrombin inactivated reaches a broad maximum in the region of 35-400. As antithrombin itself is completely stable under the conditions used, this represents a true temperature optimum for antithrombin activity. (Volkert, 1942; Koller & Fritschy, 1947 (Quick, 1938) .
The fact that antithrombin is not immediate in its action is adequate to explain why there is no significant delay of coagulation on increasing the concentration of antithrombin when coagulation times of less than 100 sec. are involved. The action of thrombin on fibrinogen certainly precedes the appearance of the clot, so that the removal of thrombin from the system by antithrombin would have to be extremely rapid to impose a delay on this early phase of the action on fibrinogen.
The non-progressive delaying action of defibrinated plasma on coagulation has not been thoroughly investigated here. The delay is not a non-specific colloid effect, for human y-globulin solution containing the same weight of protein/unit vol. as defibrinated plasma does not produce it either before or after heating; and gum acacia solutions actually cause a considerable increase in the rate of coagulation. The delay may well be due to a reversible adsorption of thrombin on to albumin, as was suggested long ago by Landsberg (1913) and more recently by Gerendas (1948) . It is, however, quite distinct from the true progressive antithrombin action, and a study of antithrombin must make use of methods which distinguish between the two effects.
Whatever may be the nature of the reaction causing the progressive decay of thrombin, it has been shown that the antithrombin responsible occurs in the oc-globulin fraction of both serum and defibrinated plasma, not in the albumin as previously supposed. Fractionation of defibrinated plasma by salt precipitation has not been successful in separating this antithrombic a-globulin from albumin, and ether precipitation has achieved only a partial separation. The problem of purifying antithrombin is the difficult one of removing a small amount of active material from a large excess of contaminant, in this case albumin, with closely similar physical properties. SUMMARY 1. The antithrombin action of defibrinated human plasma on human thrombin has been studied.
2. A method ofestimating antithrombin based on the rate of thrombin inactivation has been developed. 3. A partial purification of antithrombin has been achieved by ether fractionation of plasma; the active fraction contained 30 % oc-globulin.
4. oc-Globulin isolated electrophoretically from this fraction was shown to carry the antithrombin activity.
5. Antithrombin is stable at 370 between pH 6-0 and 8-5 and shows an optimum activity at pH 7-3.
6. At pH 7-3 antithrombin is comparatively-stable up to 500. The temperature optimum for antithrombin activity is between 35 and 40°.
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